STI/PUB/TRS461

[Pages:165]46i Technical Reports SeriEs No.

Relative Biological Effectiveness

in Ion Beam Therapy

Jointly sponsored by the IAEA and ICRU

RELATIVE BIOLOGICAL EFFECTIVENESS IN ION BEAM THERAPY

TECHNICAL REPORTS SERIES No. 461

RELATIVE BIOLOGICAL EFFECTIVENESS

IN ION BEAM THERAPY

JOINTLY SPONSORED BY THE INTERNATIONAL ATOMIC ENERGY AGENCY

AND THE INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS

INTERNATIONAL ATOMIC ENERGY AGENCY VIENNA, 2008

COPYRIGHT NOTICE

All IAEA scientific and technical publications are protected by the terms of the Universal Copyright Convention as adopted in 1952 (Berne) and as revised in 1972 (Paris). The copyright has since been extended by the World Intellectual Property Organization (Geneva) to include electronic and virtual intellectual property. Permission to use whole or parts of texts contained in IAEA publications in printed or electronic form must be obtained and is usually subject to royalty agreements. Proposals for non-commercial reproductions and translations are welcomed and considered on a case-by-case basis. Enquiries should be addressed to the IAEA Publishing Section at:

Sales and Promotion, Publishing Section International Atomic Energy Agency Wagramer Strasse 5 P.O. Box 100 1400 Vienna, Austria fax: +43 1 2600 29302 tel.: +43 1 2600 22417 email: sales.publications@

? IAEA, 2008 Printed by the IAEA in Austria

February 2008 STI/DOC/010/461

IAEA Library Cataloguing in Publication Data

Relative biological effectiveness in ion beam therapy / jointly sponsored by the International Atomic Energy Agency and the International Commission on Radiation Units and Measurements. -- Vienna : International Atomic Energy Agency, 2008. p. ; 24 cm. -- (Technical reports series, ISSN 0074?1914 ; no. 461) STI/DOC/010/461 ISBN 978?92?0107807?0 Includes bibliographical references.

1. Ion bombardment -- Therapeutic use. I. International Atomic Energy Agency. II. Series : Technical reports series (International Atomic Energy Agency) ; 461.

IAEAL

08?00503

FOREWORD

The use of ion beams for radiation therapy was first explored at the University of California's Lawrence Berkeley National Laboratory, in the United States of America, and is currently undergoing investigation at institutions in both Japan and Germany with other facilities which are under development or planned. With respect to a role in radiation therapy, ion beams have two important features arising both from the physical aspects of their dose distribution in the patient and from potentially advantageous biological phenomena resulting from their high rate of energy deposition (high linear energy transfer (LET)) over a portion of the particle track which can often be located in the tumour volume. Probably the most important of these biological phenomena is a markedly increased efficiency of cell killing. The concept of relative biological effectiveness (RBE) has been introduced to account for this increased efficiency. RBE is defined as the ratio of a dose of photons to a dose of any other particle to produce the same biological effect. RBE is a simple concept but its clinical application is complex because it is a function of particle type, energy, dose, dose per fraction, fraction number, cell or tissue type, and varies between early and late reactions following therapy.

Future developments in ion therapy will require a coherent approach to the reporting of therapies and their outcomes for comparison not only with other ion facilities but also with conventional and newly developing photon irradiation techniques. The International Commission on Radiation Units and Measurements (ICRU) has been involved in the production of a series of reports aimed at rationalizing the reporting of various forms of radiation therapy. Collaboration between the IAEA and the ICRU was initiated for proton therapy.

The present publication reflects a continuation of the collaboration between the IAEA and the ICRU, and represents a beginning step in an attempt to standardize the reporting of ion beam radiotherapy using concepts previously developed by the ICRU for reporting other therapies but with special emphasis on the use and reporting of weighting factors related to RBE. Such standardization will facilitate the comparison of therapeutic results obtained with ions not only between centres using this approach but also with centres using other modern forms of radiation therapy, such as proton and intensity modulated radiation therapy with photon beams.

A Technical Meeting on Relative Biological Effectiveness in Ion Beam Therapy, jointly sponsored by the IAEA and the ICRU, was held in Vienna, in June 2004. The meeting dealt primarily with the review of experimental measurements of RBE and approaches to the clinical use of the concept of RBE based on experimental findings, theoretical models and previous clinical

experience with fast neutrons and ions. Four of the papers presented at this meeting appear as Annexes I?IV in this publication. They were selected as examples related to methods used in different research centres.

This publication was prepared by an editorial group comprising E. Blakely of the Lawrence Berkeley National Laboratory, J. Hendry of the IAEA, and P. DeLuca, R. Gahbauer, B. Michael, A. Wambersie and G. Whitmore of the ICRU. The group was chaired by G. Whitmore. The IAEA officer responsible for this publication was J. Hendry of the Division of Human Health.

EDITORIAL NOTE Although great care has been taken to maintain the accuracy of information contained in this publication, neither the IAEA nor its Member States assume any responsibility for consequences which may arise from its use. The use of particular designations of countries or territories does not imply any judgement by the publisher, the IAEA, as to the legal status of such countries or territories, of their authorities and institutions or of the delimitation of their boundaries. The mention of names of specific companies or products (whether or not indicated as registered) does not imply any intention to infringe proprietary rights, nor should it be construed as an endorsement or recommendation on the part of the IAEA.

CONTENTS

1. RELATIVE BIOLOGICAL EFFECTIVENESS IN ION BEAM THERAPY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

1.1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.1.1. Role of radiation therapy in the treatment of cancer . . . 1 1.1.2. Present situation and future trends . . . . . . . . . . . . . . . . . 2 1.1.3. Rationale for ion therapy . . . . . . . . . . . . . . . . . . . . . . . . . 3

2. BIOLOGICAL WEIGHTING OF ABSORBED DOSE: THE SPECIFIC ISSUE OF RBE IN ION BEAM THERAPY . . . . 8

2.1. Absorbed dose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 2.2. Need for weighting factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 2.3. Reference irradiation conditions . . . . . . . . . . . . . . . . . . . . . . . . . 10

2.3.1. Radiation quality . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.3.2. Reference fractionation scheme . . . . . . . . . . . . . . . . . . . 10 2.4. Fractionated external photon therapy . . . . . . . . . . . . . . . . . . . . 11 2.4.1. Weighting factor for differences in dose per fraction . . . 11 2.4.2. Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 2.5. Brachytherapy and differences in dose rate . . . . . . . . . . . . . . . . 12 2.6. Influence of overall time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 2.7. Radiation quality and RBE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 2.7.1. The RBE concept . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 2.7.2. Application of the RBE concept in radiation

therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 2.7.2.1. RBE and dose prescription . . . . . . . . . . . . . . . 15 2.7.2.2. Selection of the most clinically relevant RBE

or weighting factors for ions . . . . . . . . . . . . . . 18 2.7.2.3. Selection of Wion based on the linear

quadratic model . . . . . . . . . . . . . . . . . . . . . . . . . 19 2.7.2.4. Evaluation of WIsoE from clinical

considerations or outcomes . . . . . . . . . . . . . . . 22 2.7.3. Ion RBE in therapy applications: Summary . . . . . . . . . 23

3. QUANTITIES AND UNITS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26

3.1. Absorbed dose, D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 3.2. Biological weighting factor, WB . . . . . . . . . . . . . . . . . . . . . . . . . . 27

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download